JP2006507850A5 - - Google Patents

Download PDF

Info

Publication number
JP2006507850A5
JP2006507850A5 JP2003579694A JP2003579694A JP2006507850A5 JP 2006507850 A5 JP2006507850 A5 JP 2006507850A5 JP 2003579694 A JP2003579694 A JP 2003579694A JP 2003579694 A JP2003579694 A JP 2003579694A JP 2006507850 A5 JP2006507850 A5 JP 2006507850A5
Authority
JP
Japan
Prior art keywords
composition
lysostaphin
biofilm
antibiotic
catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003579694A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006507850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/009354 external-priority patent/WO2003082148A1/en
Publication of JP2006507850A publication Critical patent/JP2006507850A/ja
Publication of JP2006507850A5 publication Critical patent/JP2006507850A5/ja
Pending legal-status Critical Current

Links

JP2003579694A 2002-03-26 2003-03-26 細菌バイオフィルムの酵素破壊 Pending JP2006507850A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36781902P 2002-03-26 2002-03-26
PCT/US2003/009354 WO2003082148A1 (en) 2002-03-26 2003-03-26 Enzyme disruption of bacterial biofilms

Publications (2)

Publication Number Publication Date
JP2006507850A JP2006507850A (ja) 2006-03-09
JP2006507850A5 true JP2006507850A5 (https=) 2006-06-01

Family

ID=28675404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003579694A Pending JP2006507850A (ja) 2002-03-26 2003-03-26 細菌バイオフィルムの酵素破壊

Country Status (8)

Country Link
US (1) US7572439B2 (https=)
EP (1) EP1494614A4 (https=)
JP (1) JP2006507850A (https=)
CN (1) CN1642496A (https=)
AU (1) AU2003237789A1 (https=)
BR (1) BR0308285A (https=)
CA (1) CA2476288A1 (https=)
WO (1) WO2003082148A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082926A2 (en) * 2002-03-26 2003-10-09 Biosynexus Incorporated Antimicrobial polymer conjugates
WO2004084973A2 (en) * 2003-03-24 2004-10-07 Becton, Dickinson And Company Invisible antimicrobial glove and hand antiseptic
WO2006063176A2 (en) * 2004-12-06 2006-06-15 The Government Of The Usa As Representedtd By The Secretary Of The Dept Of Health And Human Services Inhibition of biofilm formation using bacteriophage
CA2775655C (en) * 2005-01-20 2014-03-25 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Multiplexed analysis for determining a serodiagnosis of viral infection
US20070140990A1 (en) 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
US8512294B2 (en) * 2006-07-28 2013-08-20 Becton, Dickinson And Company Vascular access device antimicrobial materials and solutions
US8262645B2 (en) * 2007-11-21 2012-09-11 Actuated Medical, Inc. Devices for clearing blockages in in-situ artificial lumens
WO2009100456A2 (en) * 2008-02-08 2009-08-13 Prothera, Inc. Inhibition and treatment of gastrointestinal biofilms
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
US8821455B2 (en) * 2009-07-09 2014-09-02 Becton, Dickinson And Company Antimicrobial coating for dermally invasive devices
US20110065798A1 (en) * 2009-09-17 2011-03-17 Becton, Dickinson And Company Anti-infective lubricant for medical devices and methods for preparing the same
US20110135703A1 (en) * 2009-12-08 2011-06-09 Shipp John I Antimicrobial Coating for Surgical Implants and Method of Use
US20110135704A1 (en) * 2009-12-08 2011-06-09 Shipp John I Infection Control for Surgical and Trauma Patients
JP2014506923A (ja) 2011-03-01 2014-03-20 クオラム イノベーションズ リミテッド ライアビリティ カンパニー 病原性バイオフィルムと関連した状態を治療するための物質および方法
EP2790514A1 (en) * 2011-12-14 2014-10-22 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Process for degrading a biofilm on surfaces of objects
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9750927B2 (en) 2013-03-11 2017-09-05 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
US9327095B2 (en) 2013-03-11 2016-05-03 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
US10441744B2 (en) 2013-05-13 2019-10-15 Yannan Ouyang Flushable catheter affixed to a wash line activated by a microfluidic pressure switch
US20150182605A1 (en) * 2013-12-28 2015-07-02 StaphRx, LLC Ultra-Low Dose Lysostaphin for Treating MRSA
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
WO2015175774A1 (en) 2014-05-14 2015-11-19 Trustees Of Dartmouth College Deimmunized lysostaphin and methods of use
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
US20210112816A1 (en) * 2017-04-26 2021-04-22 Phagelux (Canada) Inc. Plasma immobilization of bacteriophages and applications thereof
US11524098B2 (en) * 2018-09-14 2022-12-13 Avent, Inc. Systems and methods for biofilm inoculation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
US5858962A (en) * 1987-05-11 1999-01-12 Ambi Inc. Composition for treating mastitis and other staphylococcal infections
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
EP0388115A1 (en) * 1989-03-13 1990-09-19 Nalco Chemical Company Controlling industrial slime
JPH02299663A (ja) * 1989-05-15 1990-12-11 Unitika Ltd 抗感染性カテーテル
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5820607A (en) * 1995-06-05 1998-10-13 Board Of Regents, University Of Texas Systems Multipurpose anti-microbial silastic sheath system for the prevention of device-related infections
IL134056A0 (en) * 1997-07-23 2001-04-30 Ambi Inc Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
US6028051A (en) * 1997-07-23 2000-02-22 Ambi Inc. Method for the treatment of staphylococcal disease
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
US6315996B1 (en) * 1999-04-09 2001-11-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Topical lysostaphin therapy for staphylococcus ocular infections
EP1198565A1 (en) 1999-07-07 2002-04-24 Maxygen Aps A method for preparing modified polypeptides
US7151139B2 (en) * 2001-04-23 2006-12-19 Massachusetts Institute Of Technology Antimicrobial polymeric surfaces
WO2003082926A2 (en) * 2002-03-26 2003-10-09 Biosynexus Incorporated Antimicrobial polymer conjugates
US7427408B2 (en) * 2002-06-06 2008-09-23 The Regents Of The University Of California Quorum sensing and biofilm formation

Similar Documents

Publication Publication Date Title
JP2006507850A5 (https=)
US8921365B2 (en) Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
JP2022163214A5 (https=)
ES2565564T3 (es) Una composición que comprende un antibiótico y un dispersante
US7572439B2 (en) Enzyme disruption of bacterial biofilms
JP7778671B2 (ja) バイオフィルム形成を阻害するためのリポソーム
US20100221237A1 (en) Enzyme disruption of bacterial biofilms
Ahmed et al. Anti-biofilm agents in control of device-related infections
WO2009013024A1 (en) Medical device and use of a pharmaceutical composition
US20070009566A1 (en) Method and apparatus for treating bacterial infections in devices
KR20180113046A (ko) 바이오필름 억제용 펩타이드
EP4048073B1 (en) Fibrinogen as adjuvant for antimicrobial agents and therapy
De Gaudio et al. What is the role of streptogramins in intensive care?
HK40071837B (en) Fibrinogen as adjuvant for antimicrobial agents and therapy
HK40071837A (en) Fibrinogen as adjuvant for antimicrobial agents and therapy
TSHIKANTWA et al. Biofilm formation Inhibition Strategy: Recent Developments